Pfanstiel Steven 4
4 · MARINUS PHARMACEUTICALS, INC. · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Pfanstiel Steven
CFO AND COO
Transactions
- Award
Stock Option (Right to Buy)
2023-01-26+126,585→ 126,585 totalExercise: $5.94Exp: 2033-01-26→ Common Stock (126,585 underlying) - Award
Common Stock
2023-01-26+28,130→ 52,128 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). The RSUs vest in three equal installments, with the first installment vesting on February 15, 2024, the second installment vesting on February 15, 2025, and the third installment vesting on February 15, 2026, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
- [F2]The option vests and becomes exercisable in 36 equal monthly installments beginning on February 26, 2023, subject to the reporting person's continued service with the Issuer.